Claim: AIDS center at UAB getting grant for HIV research.
Verdict: SUPPORTS

Retrieved passages:
title: University of Florida College of Medicine-Jacksonville
text: Daniel R. Wilson, M.D., Ph.D. The UF Health Science Center Jacksonville received $26.4 million in external support for research and training in fiscal year 2011/2012 and currently has more than 212 ongoing externally funded studies. Over the past seven years, external research funding at UFHSCJ has increased more than 350 percent. Federal-sponsored studies account for 65 percent of the UFCOM-J research awards. UF Center for HIV/AIDS Research, Education and Service (UF CARES) is the largest receipient of extramural Federal funding at University of Florida College of Medicine, Jacksonville. In addition to providing exceptional care it is an NIH funded center

title: Michael Saag
text: Michael Saag Michael S. Saag (born ) is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham (UAB). He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research. He is also the founder of the 1917 Clinic, a comprehensive AIDS treatment and research center at UAB Saag is a frequent lecturer at AIDS conferences around the world and is credited with performing pioneering clinical trials for several antiretroviral drugs now in

title: University of Florida College of Medicine-Jacksonville
text: for HIV research. UF CARES is the largest center for HIV in North Florida. The UF College of Medicine - Jacksonville is an active participant in the Clinical and Translational Science Award (CTSA) granted to the University of Florida by the National Institutes of Health. A research facility was opened in 2007 on the Jacksonville campus. The opening of the research laboratory facility resulted in an increase of research scientists joining faculty by 150 percent. The college's Dean's Office offers two internal grant competitions annually, one for Jacksonville faculty, and the other for Jacksonville residents and fellows. In 2012, the

title: University of Massachusetts Medical School
text: with HIV. Federal and private research grants and contracts at UMMS rose from about $2 million in 1977 to more than $307.6 million in 2011, putting UMMS in the top third of all research-based medical schools. UMMS currently supports more than 260 investigators working on advancements in the treatment of disease and injury. The school's portfolio of commercial ventures and intellectual property was catapulted by the success of UMMS licenses and patents (including intellectual property related to RNAi gene-silencing technology and drug and vaccine development), UMass ranked eighth in the nation in generating income from the licensing of faculty-derived discoveries

title: Beatrice Hahn
text: of Alabama at Birmingham (UAB) and established her own laboratory. She was a co-director of the Center for AIDS Research at UAB from 2003 to 2011. In 2011, Hahn joined the faculty of the Perelman School of Medicine at the University of Pennsylvania. Hahn met Robert Gallo when she was a student at the Technical University of Munich. He was a virologist and a researcher at the National Cancer Institute in Bethesda, Maryland. Most of his research was focused on leukemia, the disease that had taken his sister's life at an early age. One of the main areas of interest

title: HIV/AIDS in Australia
text: clinical trials. It also prepares the annual national surveillance reports on the disease. In 2006 the Centre received just under 4 million in Commonwealth government funding, as well as several million dollars of funding from both public and pharmaceutical industry sources. Three other research centres are also directly Commonwealth funded to investigate different facets of HIV/AIDS: the National Centre in HIV Social Research (NCHSR); the Australian Centre for HIV and Hepatitis Virology Research (ACH) (formerly the National Centre for HIV Virology Research); and the Australian Research Centre in Sex, Health and Society (ARCSHS). Research has identified anal mucus as a

title: Arkansas Children's Hospital
text: prevent illnesses and diseases in children. ACRI has about 120 scientists on staff. Recent grants include an $11.5 million award from the National Institutes of Health to establish a pediatric research center dedicated to translational research. In 2016, Arkansas Children's Research Institute received a $9.4 million award from the National Institutes of Health's Institutional Development Award program to create a center to study childhood obesity: the Center of Biomedical Research Excellence (COBRE). The grant will provide the funds over five years to support COBRE research. Running for over 35 years, Arkansas Children's Foundation has funded Arkansas Children's Hospital in research

title: Emory's Hope Clinic
text: the NIH, CDC, biomedical industry, Georgia Research Alliance, industry resources, and philanthropic contributions (including the AIDS Vaccine 200 annual bike ride). The Emory-CDC HIV/AIDS Clinical Trials Unit (CTU) and the Vaccine and Treatment Evaluation Unit (VTEU) are two major NIH grants awarded to The Hope Clinic. In 2013 The Hope Clinic moved to its current location at 500 Irvin Court, Suite 200 in Decatur, Georgia. We have grown to 65 employees and now occupy a much larger space that includes 8 exam rooms, an Investigational Drug Pharmacy, a large conference room and a large space dedicated to our research and

title: Black AIDS Institute
text: MS; Los Angeles, CA; New Orleans, LA; Oakland, CA; Philadelphia, PA; San Francisco, CA; and Washington D.C. The Institute has created a training program called the African American HIV University, that trains advocates that "work with churches, community centers, black businesses and the black media to influence policy, funding and research." This training is part of a two-year fellowship, that includes a 30-day training with the AIDS Treatment College, as well as four internships completed in different cities around the country. On their website, the Institute has listed Broadway Cares/Equity Fights AIDS, the Centers for Disease Control and Prevention, the

title: Duke University Human Vaccine Institute
text: Regional Center for Excellence in Emerging Infections and Biodefense grant from the National Institutes of Health (NIH). In 2003, the NIH funded the construction of the Duke Global Health Research Building, an infectious disease research facility and a Regional Biocontainment Laboratory (RBL). Completed in 2006, this building is designed to support basic research necessary to develop drugs, diagnostics, and vaccines for emerging infections and biodefense, and to provide surge capacity in the event of a public health emergency. In 2005, DHVI became the home to the NIAID funded Center for HIV/AIDS Vaccine Immunology, a $350M grant to speed the development

title: A. Oveta Fuller
text: in Adrian, Michigan, the science advisor the global AME Church, and an adjunct faculty member at Payne Theological Seminary where she teaches a course in the biology of HIV/AIDS. Dr. Fuller received a Fulbright US Scholar Program award in 2012 and began nine months of research in the Copperbelt region in Zambia in January 2013. The work focused on bringing biomedical information into communities through local religious leaders. A. Oveta Fuller A. Oveta Fuller is an Associate Professor of Microbiology at University of Michigan Medical School and specializes in research of the Herpes simplex virus as well as HIV/AIDS. She

title: NIH grant
text: for new grant applications are February, June, and October 5, and for renewal, resubmission, and revision grant applications are March, July, and November 5. AIDs-related grants have separate due dates. All grant-awarding institutes and centers award R01s. Applications for R01s are complex and are typically over 100 pages by submission. In financial year 2016, the NIH received 26,187 applications for new R01 grants. 17.3% were funded, for a total of $2.2 billion. The average annual budget was $460,000. Other research grant programs include: NIH grant In the United States, the The National Institutes of Health (NIH) are the primary government

title: University of Arkansas for Medical Sciences
text: in December 2008. A 1,000-car parking deck was built adjoining and underneath the hospital expansion and PRI. On Sept. 28, 2007, UAMS honored the late Winthrop P. Rockefeller, former Arkansas governor, by renaming its Arkansas Cancer Research Center (ACRC) for him while celebrating the groundbreaking for a major expansion to the facility. The 12-floor, $130 million, addition, located just north of the existing 11 story facility, allows the institute to treat more patients and host more research into new treatments. The addition opened in July, 2010. A five-floor, addition to the Jones Eye Institute opened in April 2006. It is

title: AmfAR, The Foundation for AIDS Research
text: HIV Eradication (ARCHE), and later $1.2 million to AIDS innovators. By 2016, the Countdown, along with ARCHE had granted money to 139 principal investigators and key personnel across 16 states and 9 countries. the amfAR Institute for HIV Cure Research at the University of California, San Francisco began in 2015 as the central facility to achieve their Countdown to a Cure for AIDS by 2020. It began from a $20 million grant to UCSF. Many researchers who receive fellowships and grants from amfAR and ARCHE work at the new facilities at UCSF. Under the Countdown to a Cure for AIDS,

title: Emory University
text: to study dengue virus infection in India. The Emory University Center for AIDS Research (CFAR) and the Emory Vaccine Center are world leaders in AIDS Vaccine Development and HIV Pathogenesis studies are funded by nine different institutes of the National Institutes of Health and by the Georgia Research Alliance. The centers include one of the largest groups of academic vaccine scientists in the world and are currently attempting to develop an effective HIV vaccine. Emory University Researchers Dr. Dennis C. Liotta, Dr. Raymond F. Schinazi and Dr. Woo-Baeg Choi discovered Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI) used in the

title: Centre for Infectious Disease Research in Zambia
text: be a permanent resource to, the Government of the Republic of Zambia and collaborates with the Ministry of Health and many other line ministries. The bulk of CIDRZ’s work is funded by competitive grants awarded by the U.S. government through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)/the Centers for Disease Control and Prevention (CDC) or the National Institutes of Health (NIH) research networks. Other significant support has been provided by USAID, WHO, the European Union, AERAS, Pink Ribbon Red Ribbon, the Doris Duke Charitable Foundation, Absolute Return for Kids, the Max M. and Marjorie S. Fisher Foundation, the

title: William A. Haseltine
text: Research and Human Retroviruses. Haseltine then helped design programs to transfer knowledge from academic laboratories to pharmaceutical and biotechnology companies to develop new anti viral drugs. Early on pharmaceutical companies were reluctant to initiate new research programs on HIV/AIDS. Biotechnology companies lacked the necessary funds and expertise for such work. To address this issue, Haseltine suggested that NIAID create a special grant program to encourage pharmaceutical and biotech companies to work on HIV related problems. Under this program a relatively large amount of money was granted to academic scientists provided that their laboratory have a pharmaceutical or biotechnology partner capable

title: AIDS Research Alliance
text: of Health (NIH) to develop a drug to combat HIV - prostratin. Carolyn H. Carlburg, J.D. is the current President and Chief Executive Officer, and Stephen J. Brown, M.D. is the current Vice President and Medical Director. Today, AIDS Research Alliance of America focuses its research and development program on several core areas, including the clinical trials of anti-HIV drugs that inhibit the virus in novel ways, and new medical strategies – like microbicides and vaccines – that prevent the spread of HIV. ARAA conducts clinical trials aimed at treating the medical disorders that accompany HIV, including HIV-associated lipodystrophy, diarrhea

title: Emory University
text: United States Department of Health and Human Services's National Institutes of Health. The federal agency awarded the university nearly $300 million in the fiscal year of 2015. In 2015, Emory University was one of four institutions selected by the National Institute of Allergy and Infectious Diseases for its seven-year, multimillion-dollar Tuberculosis Research Units (TBRU) program, which aims to drive innovation in tuberculosis research and reduce the global burden of the disease. In 2015, an Emory-led research consortium received a five-year, 15 million dollar grant from the National Institutes of Health (NIH) to research human immune responses to Varicella zoster virus

title: William A. Haseltine
text: this might be a moment to begin to build support for HIV/AIDS research, Haseltine enlisted the help of Elizabeth Taylor, with whom he was working in the newly created American Foundation for AIDS Research (AMFAR), and members of the Lasker Foundation. In a six-week period this small group, with the support of Senators Ted Kennedy and Ted Stevens, were able to convince Congress to add about $320 million as a supplemental appropriation to the budget of NIH specifically for HIV/AIDS research (as recounted in the book "Rapture"). Haseltine was appointed to the council of the National Institute of Allergy and